BioSpace News Archive

Integral Molecular, the industry leader in membrane protein solutions, has expanded its research facility to a second location to accommodate an upsurge in MPS Antibody Discovery partnerships and the progression of its internal therapeutic antibody pipeline

Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, today announced that ORTHO™ Sera, a suite of extended antigen phenotyping, has been cleared by the U.S. Food and Drug Administration for use on the ORTHO VISION® Analyzer.

Marine fractured her spine while bending to help her disabled mother. Lo Lan broke her hip after tripping over a loose carpet in her home..

Inscopix has entered into a research collaboration with Astellas Research Institute of America LLC, a subsidiary of Astellas Pharma Inc., to develop novel preclinical drug screening assays for psychiatric disorders.

Cyclo Therapeutics, Inc. (OTCQB:CTDH), formerly CTD Holdings, Inc., a biotechnology company that develops cyclodextrin-based products for the treatment of disease, today announced that the company has provided a grant to The Firefly Fund in support of its newborn screening program for Niemann-Pick Disease Type C.

Intelerad Medical Systems™, a leader in enterprise workflow solutions, and Zebra Medical Vision, the deep learning medical imaging analytics company, announce a joint program leveraging Intelerad’s newly released Odyssey designed to encourage the adoption of artificial intelligence without the prohibitive costs usually associated with such programs.

Following are the latest Breast Cancer Awareness Month 2019 news releases and story ideas for reporters, bloggers and media outlets

ProQR Therapeutics N.V. (Nasdaq: PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines for severe genetic rare diseases, today announced the closing of its previously announced underwritten public offering of 9,090,909 ordinary shares at a price to the public of $5.50 per share.

Novan, Inc. (“the Company” or “Novan”) (Nasdaq:NOVN) today announced that the Company has submitted a request for a pre-IND meeting with the U.S. Food and Drug Administration (FDA) for new product candidate, SB207

Diane Diamantis, co-founder of The Kelsey B. Diamantis TS Scholarship Family Foundation, Inc., dba Dollars 4 Tic Scholars, was awarded the 2019 ORG Impact Award in the Rising Star category, an individual award which recognizes “a professional with five or fewer years of experience for exceptional contribution to his/her affiliated organization.